QCA276

CAS No. 2126819-40-5

QCA276( QCA 276 | QCA-276 )

Catalog No. M13384 CAS No. 2126819-40-5

QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    QCA276
  • Note
    Research use only, not for human use.
  • Brief Description
    QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM.
  • Description
    QCA276 is a novel potent BET proteins inhibitor with IC50/Ki of 10/.3 nM, QCA276 is the BET ligand for PROTAC QCA570; effectively inhibits human BRD2, BRD3, and BRD4 BD1 and BD2 proteins with Ki of 2-20 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    QCA 276 | QCA-276
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2126819-40-5
  • Formula Weight
    401.488
  • Molecular Formula
    C22H19N5OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=NN=C2N1C3=C(COC2)C(=C(S3)C#CC4=CN(N=C4)C)CC5=CC=CC=C5
  • Chemical Name
    3-Benzyl-9-methyl-2-((1-methyl-1H-pyrazol-4-yl)ethynyl)-4H,6Hthieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Qin C, et al. J Med Chem. 2018 Jul 18. doi: 10.1021/acs.jmedchem.8b00506.
molnova catalog
related products
  • ARV-825

    ARV-825 is a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degradation of BRD4 via the proteasome.

  • BAY 299

    BAY 299 is a potent and selective inhibitor of the bromodomain and PHD finger-containing (BRPF) family protein BRD1 and the second bromodomain of TAF1 with IC50 of 6 nM and 13 nM, respectively.

  • CeMMEC13

    A selective TAF1 second bromodomain inhibitor with IC50 of 2.1 uM.